awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q34220013-F5DA7A4A-02C6-4500-A982-97F597AC6228
Q34220013-F5DA7A4A-02C6-4500-A982-97F597AC6228
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34220013-F5DA7A4A-02C6-4500-A982-97F597AC6228
A critical review of the molecular pathophysiology of lenalidomide sensitivity in 5q - myelodysplastic syndromes.
P2860
Q34220013-F5DA7A4A-02C6-4500-A982-97F597AC6228
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34220013-F5DA7A4A-02C6-4500-A982-97F597AC6228
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7fda93f427aa1081d6e7576926c55b524068360e
P2860
Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro.